The efficacy of endoxifen in treating borderline personality disorder in young female patients: reports of two cases

Tanu Singh

doi:10.18203/2319-2003.ijbcp20251844

Authors

Tanu Singh Singh Neuropsychiatry Centre, Varanasi, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20251844

Keywords:

Endoxifen, Borderline personality disorder, Protein kinase C

Abstract

This case reports presents two young female patients diagnosed with borderline personality disorder (BPD) who were treated with endoxifen. The report details their clinical presentations, previous treatment histories, the rationale for initiating endoxifen as adjunctive therapy, and the subsequent clinical outcomes. The objective is to understand the efficacy and safety of endoxifen in managing BPD symptoms, focusing particularly on impulsivity, mood fluctuations, and overall functional recovery.

Metrics

Metrics Loading ...

References

Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399(10323):473-86. DOI: https://doi.org/10.1016/S0140-6736(21)01730-X

Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, et al. The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research. Focus (Am Psychiatr Publ). 2020;18(4):456-65. DOI: https://doi.org/10.1176/appi.focus.18309

Nucifora FC Jr, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. Neurobiol Dis. 2019;131:104257. DOI: https://doi.org/10.1016/j.nbd.2018.08.016

Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: overview and treatment options. P T. 2014;39(9):638-45.

Ahmad A, Sheikh S, Khan MA, Chaturvedi A, Patel P, Patel R, et al. Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder. Bipolar Disord. 2021;23(6):595-603. DOI: https://doi.org/10.1111/bdi.13041

Ahmad A, Sheikh S, Shah T, Reddy MS, Prasad B, Verma KK, et al. Endoxifen, a New Treatment Option for Mania: A Double-Blind, Active-Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen. Clin Transl Sci. 2016;9(5):252-9. DOI: https://doi.org/10.1111/cts.12407

Kannappan Y. Endoxifen for the Management of Pathological Gambling in a Male Patient Who Overinvested in Cryptocurrency: A Case Report. Ind J Priv Psychiatry. 2024;18(2):88-90. DOI: https://doi.org/10.5005/jp-journals-10067-0184